BioPharma Credit (LON:BPCR – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.88 ($0.01), with a volume of 3483385 shares. The stock had previously closed at GBX 0.89 ($0.01).
BioPharma Credit Trading Up 0.5 %
The company has a market cap of £1.05 billion, a P/E ratio of 10.09 and a beta of 0.22. The business’s fifty day moving average is GBX 0.86 and its 200 day moving average is GBX 0.87.
BioPharma Credit Cuts Dividend
The business also recently declared a dividend, which was paid on Thursday, March 13th. Investors of record on Thursday, February 6th were issued a $0.03 dividend. The ex-dividend date was Thursday, February 6th. This represents a dividend yield of 3.4%. BioPharma Credit’s dividend payout ratio (DPR) is presently 7,957.15%.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than BioPharma Credit
- Insider Buying Explained: What Investors Need to Know
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Warren Buffett Stocks to Buy Now
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
